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Abstract
Background: Choroideremia (CHM) is a progressive X-linked retinopathy caused by mutations in the CHM gene, which
encodes Rab escort protein-1 (REP-1), an escort protein involved in the prenylation of Rabs. Under-prenylation of certain
Rabs, as a result of loss of function mutations in REP-1, could affect vesicular trafficking, exocytosis and secretion in
peripheral cells of CHM patients.
Methodology/Principal Findings: To evaluate this hypothesis, intracellular vesicle transport, lysosomal acidification and rates
of proteolytic degradation were studied in monocytes (CD14+ fraction) and primary skin fibroblasts from the nine age-
matched controls and thirteen CHM patients carrying 10 different loss-of-function mutations. With the use of pHrodo
TM
BioParticlesH conjugated with E. coli, collagen I coated FluoSpheres beads and fluorescent DQ
TM ovalbumin with BODYPY FL
dye,we demonstrated forthe firsttimethatlysosomal pHwasincreased inmonocytesof CHM patients and,as aconsequence,
the rates of proteolytic degradation were slowed. Microarrayanalysis of gene expression revealed that somegenes involved in
the immune response, small GTPase regulation, transcription, cell adhesion and the regulation of exocytosis were significantly
up and down regulated in cells from CHM patients compared to controls. Finally, CHM fibroblasts secreted significantly lower
levels of cytokine/growth factors such as macrophage chemoattractant protein-1 (MCP-1), pigment epithelial derived factor
(PEDF), tumor necrosis factor (TNF) alpha, fibroblast growth factor (FGF) beta and interleukin (lL)-8.
Conclusions/Significance: We demonstrated for the first time that peripheral cells of CHM patients had increased pH levels
in lysosomes, reduced rates of proteolytic degradation and altered secretion of cytokines. Peripheral cells from CHM
patients expose characteristics that were not previously recognized and could used as an alternative models to study the
effects of different mutations in the REP-1 gene on mechanism of CHM development in human population.
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Introduction
Choroideremia (CHM) is an X-linked monogenic disease
caused by various mutations in the CHM gene that result in the
loss of function of Rab escort protein (REP-1) and cause slow
degeneration of the retinal pigment epithelium (RPE), choroid and
photoreceptors. By the age of 40, a male patient with CHM will
typically have a significantly limited peripheral visual field, usually
at the level of legal blindness (less than 20 degrees)(Table 1).
Mutations in the CHM gene include full deletions, partial deletions
(intragenic and other), deletion/insertions, splice site mutations
and nonsense mutations [1,2,3,4]. Immunoblot analysis of protein
from white blood cells of CHM patients shows that most patients
lack REP-1 [5]. REP-1 is involved in post-translational lipid
modification (isoprenylation) of monomeric Rab GTPases (Rabs),
which are key regulators of vesicular trafficking, phagosome fusion
and maturation [1,6,7]. Seabra and colleagues first showed that
Rab27 was unprenylated in lymphoblasts of CHM patients and
was more efficiently prenylated by REP-1 than REP-2 [8]. Recent
work in C. elegans has demonstrated that rep-1 may prenylate
specific Rabs in specific tissues, such as rab-27 which is involved in
synaptic transmission, and does not participate in the prenylation
of other rabs [9]. Mammals have a CHM gene and a CHM-like
gene that encodes REP-2, which is thought to partially
compensate for the lack of REP-1 in all tissues except the eye in
CHM patients [10].
Despite our knowledge of the molecular genetics of CHM and
linked biochemical pathways, there is no clear understanding of its
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Researchers have had few suitable animal models to study the
pathogenesis of CHM. For example, a male mouse knock out
model of CHM has not been produced. The female CHM carrier
will not carry an affected male pup to term as the normal
vasculogenesis of the placenta is altered [11]. Conditional
knockouts of the Chm gene in photoreceptors and RPE of mice
have been created and have confirmed cell-autonomous degener-
ation in these tissues [12]. A number of studies have suggested that
mutations in REP-1 could cause under-prenylation of certain Rabs
and influence trafficking and outer segment disc phagocytosis by
RPE cells [13,14,15,16]. Krock and colleagues [15] used the chm
null zebrafish model to confirm that the absence of rep-1 affects
phagocytosis and trafficking in RPE cells, clearly showing defects
in the elimination of undigested outer segment disc membranes.
They suggested that the lack of rep-1 alters the rab27a/myosin7a
complex that in turn affects RPE phagocytosis [15].
Ideally, one would wish to study trafficking defects in the eyes of
CHM patients; however, eye tissue from these patients is not likely
to be available for experimentation. Human RPE cultures models
would be hard to obtain from CHM patients, and further, culture
and manipulate. Monocytes (CD14+ fraction) and primary skin
fibroblasts from CHM patients offer research material to indirectly
evaluate the effect of different mutations on the disease phenotype,
as loss of function mutations in the CHM gene are present in every
tissue of affected individuals. This approach has allowed us to
overcome the limitations of animal models and directly evaluate
the disease phenotype in different tissues. To our knowledge, this
study is the first to look at the effect of different mutations in the
CHM gene on phagocytosis, intracellular trafficking, proteolytic
degradation and secretion in monocytes (CD14+ fraction) and
primary skin fibroblasts of CHM patients carrying different
mutations in the CHM gene. Intracellular vesicle transport and
the rates of proteolytic degradation were evaluated in peripheral
cells using pHrodo
TM BioParticlesH conjugated with E.coli,
collagen I coated FluoSphere beads and fluorescent DQ
TM
ovalbumin with BODYPY FL dye. A significant increase in the
levels of lysosomal acidification and decrease in the rates of
proteolytic degradation was observed in monocytes from CHM
patients compared to controls. In addition, primary fibroblasts
from CHM patients exhibited significant differences in the uptake
and trafficking of collagen-coated beads compared to controls.
Differences in the expression of genes involved in phagocytosis,
secretion, and trafficking in peripheral cells from CHM patients
could be correlated with the clinical presentation and progression
of the disease. Under-prenylation of certain Rabs could impair
exocytosis and secretion in affected cells [17,18,19,20]. This
hypothesis was supported by the analysis of the secretory profiles of
fibroblasts derived from CHM subjects and age-matched control
fibroblast cultures. CHM fibroblasts secreted significantly lower
levels of macrophage chemoattractant protein (MCP-1), pigment
epithelial derived factor (PEDF), tumor necrosis factor (TNF)
alpha, fibroblast growth factor (FGF) beta and interleukin (IL)-8
into the media. These combined observations on peripheral cells
Table 1. Clinical characteristics of CHM patients and expected effect of determined mutations on the structure of REP-1 protein.
Patient ID,
Age (y.o.) Visual Acuity* Visual Field (III4e)
Mutation and expected
molecular mass Expected structural change
CHM 1 29 OD:20/20 OS:20/20 Central 20u, with peripheral
remnants (OU)
p.I460X; exon 10,
c.1327_1328delA; 52 kDa
REP-1 sequence ends at N442 followed by the peptide
VLTCAIQADLQGSADYRI at the C-terminus.
CHM 2 61 OD:20/20 OS:20/80 Central 2u (OU) Full deletion; 0 kDa No protein product.
CHM 3 39 OD:20/25 OS:20/40 Central 5u (OU) p.Q273X; exon 6,
Q273X;c.817C.T; 30 kDa
Protein chain is truncated after residue Q273.
CHM 4 49 OD:20/40-3 OS:20/63 Central 3u (OU) with temporal
(OD), inferior (OS) islands
p. I553X; exon 14, c.1646delC;
63 kDa
REP-1 sequence ends at W548 followed by the peptide
VFTSI at the C-terminus
{.
CHM 5 54 OD:20/640 OS:20/32 15u (OD) 10u (OS) p. I244X; deletion exons 6+7;
27 kDa
REP-1 sequence ends at K234 followed by the peptide
DMKRSHFMNI at the C-terminus.
CHM 6.1
** 18 OD:20/20 OS:20/20 Central 12u (OU) p.K234X; exon 5, c.700A.T;
26 kDa
Protein chain is truncated after residue K234. All
structural domains are affected by this change.
CHM 6.2
** 16 OD:20/20 OS:20/16 140u (OD) 150u (OS) p.K234X; exon 5, c.700A.T;
26 kDa
Protein chain is truncated after residue K234.
CHM 6.3
** 13 OD:20/20 OS:20/16 120u,w i t h2 5 u scotoma (OD);
140u with 20u scotoma (OS)
p.K234X; exon 5, c.700A.T;
26 kDa
Protein chain is truncated after residue K234.
CHM 7 54 OD:20/250 OS:HM Central 1u (OD) p.M1I; exon 1, c.3G.A; 57 kDa Protein synthesis could start from the first Met in
sequence (M149), resulting in a protein of 505 residues.
CHM 8 44 OD:20/160 OS:HM Declined testing p.L550P; exon 14, c.1679T.C,
73 kDa
Missense mutation changing the conformation and
protein stability by breaking the hydrogen-bonding
pattern.
CHM 9 74 OD:LP OS:NLP Not recordable p.Y504X; exon 13
c.1542T.A,STOP;57 kDa
Protein chain is truncated after residue Y504
{.
CHM 10 22 OD:20/12 OS:20/16 140u (OU) No mutation found; no copy
number variants
n/a
CHM 11 46 OD:20/63 OS:20/25 10u(OD), 5u (OS) (V4e) p.P179X; exon 5 c.525_526
delAG; 20 kDa
Rep-1 sequence ends at the G175 followed by the
peptide KRKP at the C-terminus (residues 176–179)
{.
*HM, hand motion; LP, light perception; NLP, no light perception.
**Brothers carrying the same mutation in Rep-1 protein.
{effect of mutations I553X, L550P, Y504X and P179X previously analyzed by Sergeev et al. 2009.
doi:10.1371/journal.pone.0008402.t001
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and will provide models to study the effect of different mutations in
the CHM gene that cause a retinal phenotype and help us to better
understand the pathogenesis of this disorder.
Methods
Patient’s Population and Study Design
This study was approved by the CNS Institutional Review
Board of the NIH (08-E1-#017). A general outline of the
experimental design is provided in Fig. 1. Informed written
consent was obtained from each subject participating in this study.
Thirteen males (age 13–74) with the clinical diagnosis of
choroideremia were accrued through referral or self-referral to
the National Eye Institute of the NIH, Bethesda, MD. An X-linked
pattern of inheritance was either inferred or evident in all cases.
Nine healthy males (age 27–78) with normal vision and no ocular
pathology were recruited to act as age-matched controls. A
complete ophthalmological examination was performed on all
subjects with fundus photography and kinetic Goldmann visual
field perimetry, where possible. For some patients, a full field ERG
was recorded using Burian-Allen electrodes through dilated pupils
according to ISCEV standards (http://www.ISCEV.org).
Peripheral blood samples (36 ml) were collected from CHM
males and age-matched male controls, in a tube system containing
sodium heparin and Ficoll Hypaque solution (Vacutainer CPT,
Becton Dickinson, NJ). After immediate density gradient centri-
fugation, mononuclear cells were collected, washed, resuspended
in 1 X PBS and separated using AutoMacs magnetic sorting to
CD14+ and CD14- populations. Cells were then counted in a
hemocytometer (Clay Adams Division of Becton Dickinson and
Co., Parsippany, NJ) and fractions of the cells were used for
phagocytic assays or frozen in Trizol (Invitrogen, Carlsbad, CA)
for RNA extraction and microarray experiments.
Primary Fibroblast Culture and Cell Viability after Drug
Exposure
Primary dermal human fibroblasts cultures were used as a
cellular model of CHM. With local anesthesia and a dermal
punch, a skin biopsy was obtained from CHM affected patients
and an age-matched healthy control group. The biopsy was
immediately minced using sterilized forceps in a 60 mm dish
containing 10% DMEM F12 media with 2.5 mg/l antibiotic/
antimycotic (Invitrogen Life Sciences, Carlsbad, CA) and
incubated for 10–14 days until fibroblasts started to attach to
the plate. Media was changed every 2–3 days. Cells were spilt once
they reached 80% confluence. As skin biopsies contain multiple
cell types, immunocytochemistry with anti-collagen I antibody was
performed on a subset of the primary culture to confirm the type
of the cells used in the study. Cells at passage 2–7 were used for
microarrays and functional studies. Cells from each patient were
seeded in 96-well micro-culture plates at 100% confluence and
oxidative injury was initiated by the treatment with 1, 10 and
50 uM of hydroquinone (HQ) in serum free media for 15 hours.
Control cells were incubated with equal volume of serum free
media. HQ was removed from the cells, replaced with regular
media for 24 hours and after that the number of viable cells was
determined by the addition of XTT- (sodium 39-(phenylamino-
carbonil)-3; 4-tetrasodium]-bis (4-methoxy-6-nitro) benzene sul-
fonic acid hydrate) using the manufacturer’s instructions (Cell
Proliferation Kit II; Roche Molecular Biochemicals, Indianapolis,
IN).
Molecular Genetic Testing
Genomic DNA was isolated from peripheral blood monocytes
and then PCR-amplified using primer pairs as previously
described [21] for analysis of all 15 coding exons of the CHM
gene and their flanking splice sites. Bi-directional DNA sequence
was obtained analyzed and compared to the published gene
sequence. Molecular genetic testing was undertaken through the
National Ophthalmic Genotyping Network, eyeGENE
TM of the
National Eye Institute, NIH.
Homology Modeling of Human REP-1
Homology modeling of mutations in human REP-1 was carried
out in a similar fashion to that described by Sergeev et al. [22].
Briefly, modeling of human REP-1 was based on the 2.2 A ˚ crystal
Figure 1. Experimental design. Collection of monocyte fractions and culture of primary dermal fibroblasts for the evaluation of gene expression
and functional differences between CHM patients and age-matched controls.
doi:10.1371/journal.pone.0008402.g001
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template (Abola et al. 1987). Primary sequences of human and rat
Rep-1 were aligned by the method of Needleman and Wunsch
[23] and incorporated in the program Look, version 3.5.2 [24] for
3-dimensional structure prediction. Full-length REP-1 and
changes in protein structure corresponding to 5 novel gene
mutations: c.1327_1328delAT (p. I460X), c.817C.T (p. Q273X),
deletion of exons 6 and 7 (p. I244x), c.700A.T (p. K234X) and
c.3G.A (p. M1I) were built by the automatic segment matching
method in the Look program followed by 500 cycles of energy
minimization. In the full-length structure of REP-1, the elements
of structure corresponding to the unresolved fragments of Rep-1
were generated in a conformation which has not been justified
experimentally in order to show the possible location and
structural role of these fragments in REP-1.
Levels of Cytokines and Growth Factors in Conditioned
Media
Levels of different cytokine/chemokines and growth factors:
IL8, MCP-1, TNF alpha, epidermal growth factor (EGF),
fibroblast growth factor (FGF), vascular endothelial growth factor
(VEGF), and PEDF were measured in aliquots of conditioned
media collected from primary fibroblasts of CHM and age
matched control patients by commercial technology (SearchLight,
Aushon BioSystems, Inc, Woburb, MA). To collect conditioned
media, cells were grown to 100% confluence, and a week later
regular media was substituted for a low serum (3%) media for
72 hours. After that, supernatant was collected, filtered, concen-
trated 2X using CentriprepH filter device (Millipore) and stored at
280uC.
Phagocytic Assay
5610
5 primary fibroblasts from CHM and control patients were
seeded onto each well of 6-well plates two days before the
phagocytic assay (Falcon, Becton Dickinson, N.J., USA) in
appropriate media containing 10% fetal calf serum. The monocyte
fraction was used for the phagocytic assay after magnetic
separation and plated either on 6 mm plates (10
6 cells per well)
or on 8 well chamber slides (5610
5 per chamber) (Lab-Tek; Nalge
Nunc International, Naperville, IL) for live cell imaging.
Phagocytosis in monocytes was tracked by pHrodo
TM BioParti-
clesH conjugate (pH dependent dye conjugated with E. coli,
(Invitrogen, Carlsbad, CA)) and in fibroblasts with collagen-coated
FluoSpheres (Invitrogen, Carlsbad, CA) using fluorescence-
activated cell sorting (FACS) and live cell imaging analysis. On
the day of the assay, regular media was replaced with SF Opti
MEM media (Invitrogen, Carlsbad CA) and the number of
BioParticles or FluoSpheres recommended by manufacturers was
added to the cells. The bead concentration was not rate limiting.
Stock solution of the pHrodo
TM BioParticlesH was 1 mg/ml and
this suspension was diluted 1:50 per sample including no-cell for
background controls. The average fluorescence value of these no-
cell background control wells was subtracted from all cell-
containing wells at the end of the assay to determine a cell-
specific, net phagocytosis signal. Cells were then incubated with
the BioParticles for 30 min (monocytes) and 60 min with the
FluoSpheres (fibroblasts) at 37uC in a humidified atmosphere
containing 5% CO
2. After that, the media containing fluorescent
particles was removed and cells were washed twice with PBS and
replaced with new SF Opti MEM. For the FACS analysis, primary
fibroblasts were trypsinized immediately before analysis at each
time point. Fluorescent and phase images of the cells were
collected by the live imaging system from 4–5 different fields every
20–30 min over 12–15 h. To measure the effect of proton pump
inhibitors on phagocytosis in CHM monocytes and fibroblasts
compared to the controls, cells were pretreated for 30 min with
10 mM of bafilomycin A1 before the phagocytic assay. Following
the treatment, cells were washed and BioParticles or FluoSpheres
were added according to the protocol.
Rate of Protein Degradation
Differences in the uptake and rate of degradation between the
CHM patient and controls was determined using self-quenched
conjugate of DQ
TM ovalbumin with BODYPY FL dye, which
exhibits green photostable and pH insensitive fluorescence upon
proteolytic degradation (Molecular Probes, Eugene, OR). Oval-
bumin conjugates are internalized via the mannose receptor–
mediated endocytosis pathway and are recognized by antigen-
presenting cells [25,26]. The increase in fluorescence correspond-
ing to the rate of degradation of engulfed DQ-ovalbumin was
measured using FACS analysis at different time points following
the feeding period.
Confocal Microscopy
Fibroblasts and monocytes imaged with the confocal microsco-
py were plated on eight-well chamber slides 24 hours before the
feeding (Lab-Tek; Nalge Nunc International, Naperville, IL). On
the day of the assay, regular media was replaced with SF Opti
MEM media (Invitrogen, Carlsbad CA) and the number of
BioParticles or FluoSpheres recommended by manufacturers was
added to the cells. Images of the cells were collected at different
time points following the feeding. Confocal microscopy was
performed on a laser scanning confocal microscope (model SP2,
with TCS software version 11.04; Leica Microsystems, Exton, PA)
using 40X and 63X objectives. Exciting with 351- and 364- nm
laser beams and collecting emissions between 400 and 500 nm
visualized staining with DAPI. Green fluorescence and AlexaFluor
488 staining was visualized by exciting with 488-nm laser beam
and collecting emissions between 500 and 552 nm. pHrodo
TM
BioParticlesH conjugate were visualized by exciting with a 568-nm
laser beam and collecting emissions between 580 and 650 –nm.
Scale bars are digitally included in some images.
RNA Isolation and Expression Profiling
Fibroblasts and monocytes were collected, homogenized in
TRIzol reagent (Invitrogen, Carlsbad, CA) and RNA was
subsequently purified using an RNeasy Mini kit (Qiagen Inc,
Valencia, CA). Double-stranded cDNA was synthesized from 6 mg
of total RNA using the SuperScript Choice system (Invitrogen,
Carlsbad, CA) and the T7-Oligo (dT) promoter primer kit
(Affymetrix, Santa Clara, CA). cDNA was purified using Phase
Lock Gels (Eppendorf, Westbury, NY). Biotin-labeled cRNA was
then synthesized from double-stranded cDNA using the BioArray
High Yield RNA transcript labeling kit (Enzo Diagnostics, Santa
Clara, CA). cRNA was purified using an RNeasy Mini kit (Qiagen
Inc, Valencia, CA) and fragmented into 35–200 base pair
fragments by metal-induced hydrolysis (200 mM Tris-acetate,
pH 8.2, 500 mM KOAc, 150 mM MgOAc) at 94uC for 35
minutes. Fifteen micrograms of fragmented biotin-labeled cRNA
was hybridized onto Human Genome U133 Plus 2.0 GeneChips
(Affymetrix, Santa Clara, CA) for 16 h at 45uC and 60 rpm.
GeneChips were then washed and stained as per the Affymetrix
GeneChip Expression Analysis Manual (Affymetrix, Santa Clara,
CA). This procedure includes the removal of non-hybridized
material. Staining was then performed with phycoerythrin-
streptavidin and signal amplification by a second staining with
biotinylated anti-streptavadin and phycoerythrin-streptavidin.
Fluorescence from hybridized cRNA was detected using the
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measures included a requirement that scaling factors, percent of
genes called present, average intensity, background values,
housekeeping 39/59 ratios and measured intensities of spiked-in
controls all fall within predefined ranges. Additionally, only
samples with ‘acceptable’ amplification at the T7 RNA polymer-
ase cRNA step were hybridized onto the chips.
RT-PCR Validation Using TaqMan
Levels of mRNA in fibroblasts were confirmed by real time
PCR using TaqMan one step RT-PCR and ABI Fast System 7900
(Applied Biosystems, Foster City, CA). Rt reactions were
performed on 10 ug of total RNA and the total volume of the
PCR reaction was 10 mL. The thermocycler parameters were
95uC for 10 min, followed by 40 cycles of 95uC for 15 s and 60uC
for 1 min. Relative changes in gene expression were calculated
using a variation of the DDCt method. This method first subtracts
from the gene threshold cycle (Ct) value, the average of the Ct
values of 5 housekeeping genes (B2M, HPRT1, RPL13A,
GAPDH, and ACTB), yielding a DCt value normalized to the
RNA amounts for each of the four conditions studied. The DDCt
for each of the group was calculated by subtracting the mean DCt
of the four groups from the DCt for each individual group. There
were at least 3 biological replicates in each group.
Protein Analysis
Fibroblasts, cultured adult RPE (ARPE19), human fetal RPE,
human vascular endothelial cells (HUVEC), and peripheral blood
mononuclear cells (PBMCs) were collected, washed and homog-
enized in RIPA buffer (1% NP-40, 1% sodium deoxycholate, 0.1%
SDS, 150 mM NaCl, 25 mM TrisHCl, pH 7.6) and a cocktail of
protease inhibitors (Complete, Roche, Indianapolis, IN). Protein
concentration in extracts was determined using BCA reagent
(Pierce Biotechnology, Rockford, IL). Equal amounts of protein
were loaded and separated by SDS-PAGE in 4–12% NuPAGE
Novex Bis-Tris Gels and NuPAGE MOPS SDS running buffer
(Invitrogen, Carlsbad, CA) and then electro-transferred to 0.45-
mm nitrocellulose membranes (Invitrogen, Carlsbad, CA). The
membranes were probed with mouse monoclonal anti-REP-1
antibody, clone 2F1 (Santa Cruz Biotech, Santa Cruz, CA)
generated against the 415 C-terminal amino acids of Rep1 [5,27]
and anti-REP-2 antibody C-20 (Santa Cruz Biotech, Santa Cruz,
CA). Immunoreactivity was detected with a corresponding second
anti-IgG antibody conjugated with horseradish peroxidase (Zymed
Lab. Inc., San Francisco, CA) and imaged with X-ray film using
SuperSignal West Pico Chemiluminescent Substrate (Pierce,
Rockford, IL).
Fluorescent Detection Using FACS Analysis
In brief, primary control and CHM monocyte or fibroblast
cells were analyzed at the NIH Gene Therapy Flow Core using a
FACSCanto (Becton Dickinson, San Jose, CA) equipped with a
Coherent Sapphire 488 blue and JDS Uniphase HeNe Air
Cooled 633 red laser. Cells containing pHrodo-TM Bioparticles-
R, DQ-ovalbumin-BODYPY FL-dye or collagen-coated Fluo-
Spheres were analyzed with BD FACSDiva software (Becton
Dickinson, San Jose, CA). Appropriate gating of forward and side
s c a t t e re x c l u d e dd e a dc e l l s ,u n i n c o r p o r a t e dp a r t i c l e s ,a n dd e b r i s .
Intensity of pHrodo fluorescence was measured with a 585/42
(564–606 nm) band pass emission filter and collagen-coated
FluoSpheres and DQ-ovalbumin-BODYPY FL-dye were mea-
sured using a 530/30 (515–545 nm) band pass emission filter.
Negative controls (unfed cells and no cells plus particles) were
used to establish background and autofluorescence. For each
sample, 5000 live-gated cells were acquired for all analyses.
Positive (‘‘shifted’’) cellswere gated and compared to the negative
control.
Microarray Data Collection and Normalization
The signal intensity for each of 54,675 probesets on the
hybridized Affymetrix Human Genome U133 plus 2.0 chips was
calculated using the MAS5 algorithm implemented in the
GeneChipH Operating Software 1.4 (Affymetrix, Santa Clara,
CA). Signal intensity values were normalized using an adaptive
variance stabilizing, quantile-transformation named S10 (PJ
Munson, GeneLogic Workshop of Low Level Analysis of
Affymetrix GeneChip Data, 2001, software available at http://
abs.cit.nih.gov/MSCLtoolbox). In order to apply statistical tests to
the data, the variance of the replicates should be nearly uniform
over the range of expression levels. The S10 transformation
approximates a common logarithm transform over the central
working range of the assay and thus differences of S10-
transformed data values can be interpreted as log ratios or simply
‘‘log-fold changes’’. A major advantage of this approach over the
ordinary log-ratio is that changes in S10-transformed values have a
uniform variance over the full expression scale. Data were
collected under the MIAME compliant format and the raw data
have been deposited into the Gene Expression Omnibus hosted by
the NCBI (GEO; http://www.ncbi.nlm.nih.gov/geo/query/.
With query accession no: GSE17549).
Outlier Detection and Statistical Analysis
Visualization of the global relationships between the samples
and detection of possible outliers among the 16 samples was
facilitated by principal component analysis (PCA) of the S10
transformed data. PCA is a statistical technique used for
representing high dimensional data in a few dimensions in order
to visualize the relative location of the chips. Plotting the principal
components containing the largest amount of variability against
one another allows for outlier detection between the samples.
Because different cell types (monocytes and fibroblasts) and two
distinct preparationtechniquesfor monocyteswereused, CHMand
control samples were compared separately for each of three groups.
To address variability between the samples a consistency test was
used to determine significance of observed differences between
CHM and control samples http://stat- http://stat-www.berkeley.
edu/users/terry/zarray/Affy/GL_Workshop/genelogic2001.html
[28,29]. The false discovery rate (FDR) was calculated from the
consistency test p-values [30].
Biological Process Categorization by Gene Ontology
Functional annotation and classification, identification of
significantly enriched biological themes using the Gene Ontology
terms and classification of protein functional domains were
explored in RPE gene signature list using The Database for
Annotation, Visualization and Integrated Discovery (DAVID)
bioinformatics resource (http://david.abcc.ncifcrf.gov/), and
Expression Analysis Systematic Explorer (EASE) (http://apps1.
niaid.nih.gov/david). Significant overrepresentation of function-
al classes of interest in the in RPE gene signature list was
determined using GO terminology ‘‘biological process’’ (http://
www.geneontology.org). This approach allows one to determine
which particular functional categories are significantly overrep-
resented in the list of RPE specific gene. EASE score or Fisher’s
exact test p–value was used to measure significance of the gene-
enrichment of the annotation terms within each biological
process category.
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The Phenotype of CHM Patients
ClinicaldatafromCHMmalepatientsareshownintheTable1.
Many males with CHM had mild to high myopia ranging from
20.50 to 210.625 (spherical equivalent, mean 22.83, n=20 eyes).
Retinal findings varied with the age of patients, with younger
patients showing areas of moderate, widespread RPE atrophy
(Fig. 2A). Older patients showed extensive choriocapillaris and
RPE atrophy with preservation of central function and in later
stages, retinal vessel attenuation and optic nerve pallor (Fig. 2B).
The horizontal continuous visual field of patients showed a general
decline with age. The visual field was estimated with the III4e target
of Goldmann perimetry in patients ages 13 and 22 to be to 12–145
degrees (n=8 eyes); at ages 29–49, 5–20 degrees (n=10 eyes); and
finally at ages 54–74, from no recordable field to 15 degrees (n=8
eyes). The full field ERG of a patient at age 22 (CHM10) showed
reduced scotopic and photopic a and b wave amplitudes and flicker
responses. At age 29, the ERG of another patient (CHM1) showed
severe reduction in the amplitudes of the scotopic b wave and
photopic responsesonly 10% of normal. In 2 older patients, aged 49
(CHM4) and 54 (CHM5), the amplitudes of the photopic flicker
ERGs measured approximately 2 mV( Table 1).
The Genotype of CHM Patients
Molecular genetic testing of DNA from the CHM patients
(CHM1–CHM11) revealed 9 different mutations located in
e x o n s1 ,5 ,6 ,7 ,1 0 ,1 3a n d1 4( Table 1). Patient CHM2 had a
full deletion of the CHM gene and CHM10 patient had no
mutation in the coding sequences of the CHM gene or in adjacent
splice sites. This patient had clinical features of CHM (Fig. 2A);
real time PCR analysis failed to show copy number variants of
any of the exons of the CHM gene, but protein analysis confirmed
absence of REP-1 (data not shown). The mutation in this patient
is possibly localized within an intron or the 5-prime region of the
gene.
For each of the other 9 mutations, the predicted size of the
protein product and the structural change in REP-1 are presented
in Table 1. Five mutations are newly described in this study:
c.1327_1328delAT (p.I460X), c.817C.T (p.Q273X), deletion of
exons 6 and 7 (p.I244X), c.700A.T (p.K234X) and p.M1I; and 4
mutations were structurally characterized previously:
c.525_526delAG (p.P179X); c.1542T.A, STOP (p.Y504X) and
c.1646delC (p.I553X) and p.L550P (Sergeev et al, 2009). The
effect of mutations K234X, I244X, Q273X and I460X on REP-1
structure is demonstrated in Fig. 3A. The truncated parts of the
REP-1 molecule are shown in red. All nonsense mutations result in
a truncated protein product with unstable protein structure and
loss of critical REP-1 function. The missense mutation M1I
(Table 1) occurs at the start site (ATG) resulting in a truncated
protein product (white ribbon, Fig. 3B) with the loss of REP-1
domain structure. Molecular modeling of the missense mutation,
L550P, predicted that the structure of the protein is unstable
which could be one of the mechanisms of REP-1 loss [22].
Figure 2. Fundus photographs of the control and CHM patients. a. CHM patient 22 y.o. characterized by RPE depigmentation and
widespread RPE disruption b. CHM patient 74 y.o. characterized by loss of RPE and choroid, scattered pigment in macula, faint deep choroidal vessels
and severely narrowed retinal vessels and optic nerve pallor (Table 1, CHM 9 and 10 respectively). c. Female CHM carrier, age 50 showing patchy RPE
hypopigmentation without pigment dispersion and control subject. d. Fundus photograph of the normal eye.
doi:10.1371/journal.pone.0008402.g002
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the fibroblasts from all patients carrying these mutations (Fig. 3D).
REP-1 and REP-2 Expression
Microarray and quantitative PCR analysis confirmed that
fibroblasts and monocytes from CHM patients with different
mutations express CHM mRNA at different levels. CHM subjects
1, 5, 7, 8, and 11 (CHM group 2) express CHM mRNA at levels
similar to controls but the levels of CHM mRNA in CHM subjects
2, 4, 6 and 9 (CHM group 1) were 8–20 times lower (Fig. 3C).
Similar CHM mRNA levels were obtained for monocytes and
fibroblasts derived from the same patient. This result could be
explained by the nature and position of the mutations, and their
effect on the structure of mRNA. In those with premature
termination codons, the mRNA could potentially be targeted for
nonsense-mediated decay; while in others, the mutations could
affect the stability of the mRNA [31].
Levels of REP-1 protein expression varied in different cell types,
with less expression in monocytes and ARPE19 cells compared to
human fetal RPE cells, fibroblasts or vascular endothelial cells
(Fig. 3D). We determined that the levels of REP-1 and REP-2
expression are quite variable between different human tissues. We
also observed a lack of apparent correlation between the REP-1
and REP-2 levels in these cells, which could indicate another
compensatory mechanisms employed by the peripheral cells in
CHM patients.
Phagocytosis in Monocytes of CHM Patients and Controls
E. coli particles conjugated with a pH-dependent fluorescent dye
(pHrodo
TM BioParticlesH) were used to track the phagocytic
process in monocytes from CHM patients and healthy age-
matched controls. In the neutral pH outside and inside the cell, the
light emission by pHrodo conjugated E. coli is dim and barely
detectable by the fluorescent microscope or flow cytometry
analysis (FACS). Once BioParticles are engulfed, the acidic
environment within the phagolysosome causes a significant
increase in fluorescent emission by the particles. The use of pH-
dependent BioParticles allowed us to determine the number of
phagocytosing cells in the population, the kinetics of uptake and
change in pH of the lysosomes. Monocytes from 8 CHM patients
with different CHM mutations and 6 age-matched controls were
compared over time for different aspects of phagocytosis and
Figure 3. Effect of different mutations on the structure and levels of REP-1 mRNA and protein. a, Effect of different nonsense mutations
on the structure of REP-1 protein (Q273X, I460X, M1I and K234X). b, Distribution and position of the mutations in the REP-1 protein, note that 4 of 9
mutations localized in the beta sheet of the REP-1 (blue) and 7 of 9 mutations (P179X, K234X, I244X, I460X, Y504 X, L550P and I553X, Table 1)
localized to domain 2 of the REP-1 protein. c. Levels of mRNA determined by the microarray analysis of the expression profiles from monocytes and
fibroblasts from CHM and control patients. Control group, n=5; group CHM1 includes patients with low levels of REP1 mRNA, n=7; group CHM2
includes patients with REP-1 mRNA similar to the controls, n=6. d. Expression levels of REP-1 and REP-2 in different cell types derived from CHM and
control patients. Lane: 1, 10 ng of rat recombinant REP-1 or 10 ng of rat recombinant REP-2 with HisTag; cell lysates (40 mg of protein for each) 2,
ARPE19; 3, human fetal RPE; 4, MO- monocytes from control; 5, MO-monocytes from patient CHM4; 6, cultured human umbilical vein endothelial cells
(HUVECs); 7, primary fibroblasts from control; 8, primary fibroblasts from CHM2 patient. b-actin was used as a loading control.
doi:10.1371/journal.pone.0008402.g003
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Cells from CHM subjects were analyzed in parallel with
appropriate age-matched controls and results were reproduced
in 6 independent experiments. FACS and confocal microscopy at
1 h, 3 h and 5 h following the feeding confirmed the increase in
fluorescent intensity of BioParticles engulfed by monocytes
(Fig. 4A, C). Dramatic increase in fluorescence intensity was
observed for 67–89% of the control and patients monocytes one
hour after the feeding with E. coli pHrodo. Confocal imaging of the
phagocytosing CHM and control monocytes demonstrated the
presence of fluorescent BioParticles inside of the phagolysosomes
(Fig. 4A right panel). FACS analysis was done on the large
population of phagocytosing monocytes from 7 CHM and 6
controls to determine the differences in fluorescence intensity of
the cells following the feeding (Fig. 4B, C). Flow cytometry
analysis showed that CHM monocytes uptaking E. coli pHrodo
demonstrated consistently lower levels of fluorescence compared to
controls. The biggest difference in fluorescence levels was observed
by 3 h following feeding with the BioParticles (11686345 in CHM
monocytes, 17536453 in controls) (Fig. 4B). These results are
consistent with the hypothesis that phagolysosomes in monocytes
from CHM patients do not develop the same level of acidification
as control monocytes resulting in a relative decrease in
fluorescence levels. The increase in pH level of the phagolyso-
somes could affect the ability of the cells to adequately process and
degrade engulfed material.
The efficiency of lysosome-mediated degradation by monocytes
was further evaluated with DQ
TM ovalbumin particles with
BODYPY FL dye. DQ-ovalbumin is a self-quenched substrate for
proteases, which becomes fluorescent after proteolytic cleavage.
Using this system, we evaluated the effect of increased acidification
on proteolysis in lysosomes of monocytes from CHM patients and
controls. FACS analysis of the monocytes from 7 CHM patients
and 6 controls following feeding with DQ-ovalbumin particles
confirmed lower levels of fluorescence in CHM patients, which
reflected decreased rates of DQ-ovalbumin degradation by the
Figure 4. Levels of lysosomal acidification and proteolytic degradation in monocytes from CHM patients and age-matched
controls. a. Intralysosomal acidification measurements were performed using E. coli BioParticles conjugated with pH dependent dye (pHrodo).
Representative confocal images of the monocytes from patient CHM8 (right panel) and age matched control (left panel) feed with BioParticles at 3 h
following the feeding. Acidic environment of the lysosomes caused an increase in fluorescent intensity of the BioParticles engulfed by the cells (in
red, blue is a DAPI nuclear staining). b. Levels of fluorescence of the monocytes from CHM (n=7) and control (n=6) patients feed with BioParticles
were analysed by flow cytometry, data expressed as a mean fluorescence intensity+/2SED at 1, 3 and 5 h following the feeding. Fluorescence
intensity of pH dependent BioParticles taken up by monocytes from CHM patients was lower compared to the control at each time point. c.
Representative FACS histograms showing shift in fluorescence intensity between the CHM and control monocytes fed with E. coli pHrodo at 1, 3 and
5h .d. The efficiency of lysosome-mediated proteolytic degradation by monocytes from CHM (n=7) and control (n=6) patients assessed with DQ-
ovalbumin particles. DQ-ovalbumin is a self-quenched substrate for proteases, which becomes fluorescent after proteolytic cleavage. Increase in
fluorescence intensity, corresponding to the rate of proteolytic degradation of DQ-ovalbumin, was measured by flow cytometry. Data was expressed
as a mean fluorescence intensity of the cells+/2SED at 1, 3 and 5 h following the feeding. Rates of proteolytic degradation were significantly lower in
monocytes from CHM patients compared to control (N p=0.005).
doi:10.1371/journal.pone.0008402.g004
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3 h following feeding (17396696 in CHM monocytes,
263661084 in controls) and at 5 h the difference became
statistically significant (14996526 in CHM monocytes,
320061548 in controls; p,0.05) (Fig. 4D). Some patients
displayed a certain degree of the variability in the fluorescence
intensity that may be due to the potential residual activity of some
mutant forms of REP-1.
Level of Acidification and Rate of Degradation of DQ-
Ovalbumin Affected in CHM and Control Monocytes after
the Treatment with Bafilomycin A1 (BafA1)
To confirm that the increase in lysosomal pH affected the ability
of monocytes to degrade engulfed material, cells from controls and
CHM patients were treated with the vH+ATPase inhibitor,
bafilomycin A1. A number of studies have demonstrated that
bafilomycin A1 causes an increase in pH inside the lysosomes,
leading to a decrease in the rate of degradation of material in
lysosomes [32]. Change in the acidification of lysosomal
environment of monocytes was measured by the change in
fluorescence of pH-dependent BioParticles (Fig. 5A–C) and the
rate of proteolytic degradation in lysosomes was measured using
DQ-ovalbumin. CHM and control monocytes were pretreated
with 100 nM bafilomycin A1 for 30 min before the feeding. FACS
analysis of the monocyte population from CHM patients (n=3)
and controls (n=3) at 1, 3 and 5 h following the treatment with
bafilomycin A1 demonstrated a decrease in the levels of
fluorescent intensity of engulfed pH-dependent BioParticles in
both controls and patients. CHM and control lysosomes
demonstrated a decrease of 7–47% in fluorescence intensity
depending on the time point. The fluorescence level for a selected
patient before and after bafilomycin A1 treatment is shown in
Fig. 5B. Corresponding rates of DQ-ovalbumin degradation were
also decreased in both CHM and control monocytes 1 and 3 h
following pre-treatment with bafilomycin A1 (Fig. 5D). These
results confirm that decreased acidification in lysosomes affects the
proteolytic abilities of CHM and control monocytes.
Figure 5. Lysosomal acidification and rate of proteolytic degradation in monocytes from CHM and control patients treated with
Bafilomycin-A1 (BafA1). a. Lysosomal acidification and rate of proteolytic degradation in monocytes from CHM and control BafA1. Intralysosomal
acidification measurements were performed using E. coli BioParticles conjugated with a pH dependent dye (pHrodo). Treatment caused an increase in
lysosomal pH as evident by a decrease in the fluorescence of BioParticles (confocal images, left panel vehicle no effect, right panel cells pre- treated
with BafA1 for 30 min, decreased fluorescence). b. Decrease in fluorescence levels of BioParticles following the treatment with BafA1 in monocytes
from control and patient CHM4 measured by flow cytometry analysis at 1, 3 and 5 hours following the feeding. c. Representative FACS histograms
showing a shift in fluorescence intensity of the CHM and control monocytes fed with BioParticles treated with BafA1 at 1, 3 and 5 h. d. Decreased rate
of DQ-ovalbumin degradation in CHM (n=3) and control (n=3) patients before and after the treatment with BafA1 measured by flow cytometry
analysis at 1, 3 and 5 hours following the feeding. Data expressed as a percent of fluorescence reduction in CHM and control cells treated with BafA1,
compared to the non-treated (NT) cells.
doi:10.1371/journal.pone.0008402.g005
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CHM Patients
Primary dermal fibroblasts from 7 CHM patients and 6 controls
were used to determine if trafficking defects observed in monocytes
from the CHM patients were present in other peripheral cells of the
patients. Phagocytosis in primary fibroblasts was tracked and
quantified using collagen I coated FluoSpheres beads. The rate of
uptake was significantly lower in fibroblasts from CHM patients
compared to controls 1 h following feeding; after that, CHM
patients demonstrated similar rates of uptake (Fig. 6B). The
number of cells taking up particles was consistently smaller over the
16 h time period in primary cultures of CHM patients (Fig. 6C).
CHM fibroblasts cultures fed with beads were also less resistant to
the oxidative stress initiated by treatment with 1 mMa n d1 0mMo f
hydroquinone (HQ) (Fig. 6D). These data imply that primary
fibroblasts from CHM patients exhibit a number of defects in the
trafficking system when compared to the control cells.
Microarray Analysis of Expression Profiles of CHM and
Control Patients Derived from Monocytes and Fibroblasts
PCA and hierarchical cluster analysis were performed on
expression profiles of 16 samples to evaluate the grouping between
the primary fibroblasts cultures and monocytes from CHM and
control patients. Differentially expressed probesets were deter-
mined from the comparison of 11 CHM patients’ monocytes and
primary fibroblasts to those of 5 control subjects using a
consistency test [28,29]. The dendrogram of the hierarchical
clusters of twenty-six probe sets that are significantly over-
expressed and twenty-one probe sets that are under-expressed in
CHM patients is shown on the Figure 7A (p,0.0001, FDR 30%).
The Database for Annotation, Visualization and Integrated
Discovery tool (DAVID) was used to carry out a functional
classification and annotation and ascertain the enrichment of
particular biological gene ontology categories (GO)[33]. Func-
tional categories affected in both fibroblasts and monocytes of
CHM patients included a large group of genes involved in
regulation of cell adhesion and motility (NCAM-2, FMN1,
ANKRD28, CSF3R, DMD, MLLT4, DPP4, TSPAN5, CD114,
DMD, CYFIP2, WNT5A, MMP7), immune response (IL1, CC2,
CFI, ELOVL2), regulation of trafficking and exocytosis (RGS11,
SYT 6, GBF1) and transcriptional regulation (HOXD11, MRO,
NRG1, NLRC3, NR2F6, SALL1, DIP2A, RSOPO2) (Fig. 7A).
Interestingly, expression levels of genes encoding secreted proteins
from different functional groups including CFI, CC2, NRG1,
MMP7, WNT5A, RSOPO2, CSF3R, DPP4, IL1 were deregu-
Figure 6. Differential uptake of collagen coated beads (FluoSphere) by primary fibroblasts from CHM and control patients. a.
Confocal image of the fibroblasts 1 h after the uptake of collagen coated fluorescent beads. Note that beads were internalized into the cytoplasm. b.
Rates of bead uptake 1 h following feeding was significantly higher in the control cells (n=7) compared to the CHM patients (n=6) as measured by
flow cytometry. Data expressed as mean fluorescence intensity+/2SED at 1, 3, 5 and 16 h. After that CHM cells demonstrated a similar rate of the
uptake. c. Percent of cells taking up beads was consistently higher in the control cells (16 h period). d. CHM fibroblasts (n=5) cultures fed with beads
less resistant to the oxidative stress initiated by the treatment with 1 mM and 10 mM of hydroquinone (HQ) when compared to controls (n=3).
Viability levels were measured using XTT and expressed as percent viability of non-treated non-fed cells.
doi:10.1371/journal.pone.0008402.g006
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before, impairment of decreased acidification in lysosomes and
proteolytic degradation could affect exocytosis and secretion
processes by the cells. We hypothesized that cells derived from
the CHM patients could have a general impairment in the
mechanism of exocytosis.
Levels of Cytokine and Growth Factors Released by the
Primary Fibroblast Cultures Derived from the CHM
Patients
To determine the effect of mutant REP-1 on secretion of
cytokines and growth factors by the peripheral cells, conditioned
media samples were collected from the primary fibroblast cultures
of 8 CHM patients and 9 controls. Levels of IL-8, MCP-1, TNF-
alpha, FGF and PEDF factors were significantly higher in samples
collected from the control cells (p,0.005), and levels of VEGF and
EGF did not change significantly. The results were confirmed in 3
independent experiments. Primary fibroblasts from CHM patients
released 3.2 fold less IL8, 4 fold less MCP1, 2.8 fold less TNF-
alpha, 2.33 fold less FGF and 1.6 fold less of PEDF. Actual levels
of secretion of MCP-1, TNF-alpha and FGF for all the controls
and CHM samples are presented in Fig. 7B, C and D. Reduced
levels of secretion of multiple factors corroborate the results of the
microarray analysis and point to the possible impairment of the
secretion process by cells expressing mutant REP-1.
Discussion
CHM is a monogenic disease caused by various mutations in
the CHM gene that result in the loss of function of Rab escort
protein (REP-1) and cause slow degeneration of RPE, choroid and
photoreceptors. While many genetic studies have characterized
the types of mutations in REP-1 in CHM patients, few have added
to our understanding of the pathogenesis of the disease. REP-1 is
involved in the prenylation of Rabs (small Ras superfamily
GTPases), which are essential for phagocytosis, secretion and
intracellular trafficking in variety of tissues throughout the body
[1,27,34]. A CHM-like gene in mammals encodes REP-2, which is
thought to partially compensate for the lack of REP-1 in all tissues
except the eye in CHM patients [10]. Normally REP-1 is
Figure 7. Mutation in REP-1 affects gene expression and secretion in CHM patients. a. Hierarchical cluster of 47 probe sets in control and
CHM samples. Using consistency testing, twenty-six probe sets were found to be significantly over-expressed and 21 under-expressed in monocytes
and primary fibroblasts cells from CHM patients 43 (CHM 6-15) compared to control (Cont 1-5)(p,0.0001, FDR30%) b-d. Level of secretion of the
cytokines and growth factors by primary fibroblast cultures into conditioned media. MCP-1, TNF-alpha and FGF factors were detected at significantly
higher levels in samples collected from the control cells (n=9) compared to conditioned media samples from 8 CHM patients (p,0.005)
doi:10.1371/journal.pone.0008402.g007
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absence of REP-1 affects only the retina. One suggestion was that
certain Rabs are prenylated more efficiently by REP-1 than REP-
2 [35]. For example, Rab27 is under-prenylated in lymphoblasts
from the CHM patients and probably preferentially requires REP-
1 [8]. Rab27 is also present at high levels in the RPE and
choriocapillaris and its under-prenylation could contribute to the
degenerative process. To study phagocytosis, secretion and
intracellular trafficking in CHM patients, we are limited by the
lack of functionally relevant cell culture models pertinent to the
eye, which are functionally deficient in REP-1. For example,
human RPE cultures models would be hard to obtain from CHM
patients, and further culture and manipulate. The use of
peripheral cells and primary cultures derived from CHM patients
could be extremely helpful since the existing paradigm for CHM
pathogenesis is lacking a number of key data regarding the tissue
specificity of REP-1 regulation. In addition, peripheral cells and
primary cultures were derived from CHM patients with variety of
mutations could help to confirm if different mutations cause
similar phenotypes. This approach has allowed us to overcome the
limitations of animal models and directly evaluate disease
phenotype in different tissues. To our knowledge, this is the first
study to look at the effect of different mutations in REP-1 on
phagocytosis, trafficking and proteolytic degradation in peripheral
tissues of CHM patients.
Phagocytosis and Proteolytic Degradation Is Altered in
Monocytes from CHM Patients
Monocytes from CHM patients demonstrated a consistent
increase in lysosomal pH when compared to controls. Since an
increase in lysosomal pH leads to the inhibition of lysosomal
hydrolases, this could dramatically affect the ability of these cells to
process and degrade engulfed material [32,36]. Indeed, using a
self-quenched DQ-ovalbumin particle system, we confirmed that
the decreased acidification of lysosomes of CHM patients
significantly affected proteolytic abilities of the monocytes
[25,26]. Monocytes from different CHM patients demonstrated
significant variation in the rates of uptake of material, lysosomal
acidification and protein degradation, which could be explained
by the effects of different mutations in the CHM gene on structure
and function of REP-1. Monocytes from CHM patients showed
the same functional defects when compared to controls.
The RPE serves a number of vital functions in the eye including
daily phagocytosis and degradation of shed photoreceptor outer
segments; maintenance of the visual cycle by the uptake,
processing, and transport of vitamin A; and the transport of
nutrients between the choroid and the RPE [37,38,39,40].
Dysfunctional lysosomal processing in the RPE could contribute
to the pathophysiological events that cause RPE damage and
degeneration of the neurosensory retina [41,42]. Bergmann and
coworkers demonstrated that A2E, which accumulates in age-
related macular degeneration (AMD), impaired the proton pump
of the lysosomal membrane in cultured RPE, altered the function
of the lysosome and thereby slowed the processing of photore-
ceptor outer segments [36]. Impaired lysosomal function and
protein degradation abilities in RPE likely play a significant role in
the development of AMD and also chloroquine-induced retinal
degeneration [17,43,44,45,36]. Chloroquine accumulation within
the retina increases lysosomal pH, reduces the activity of lysosomal
enzymes and leads to the accumulation of undegraded oxidized
residual material [41]. Further, inhibition of lysosomal enzymes in
the RPE leads to attenuation of exocytosis and release of
incompletely degraded phagolysosomes into the basal and
intercellular spaces between adjacent cells [17,20,46]. Post-mitotic
cells like the RPE, with an extended lifetime and low turnover in
vivo, may be especially susceptible to toxicity and degeneration
caused by defects in lysosome-mediated degradation and impaired
secretion. The RPE and photoreceptors in a chronic disorder such
as CHM are probably constantly subjected to the stress caused by
the lysosomal dysfunction and accumulate sub-toxic changes with
age, which lead to the development of disease. We observed, for
example, that fibroblasts of CHM subjects were less resistant than
controls to oxidative stress induced by hydroxyquinone, and could
suggest that the cells of the RPE of these subjects are similarly less
resistant to oxidative stress than normal subjects.
The altered cellular phenotype of fibroblasts and monocytes
from CHM patients carrying knockouts and missense mutations of
the CHM gene complement and expand the existing data resulting
from knock down of the main transcript of the CHM gene in
cultured human fetal RPE cells [47]. The siRNA approach on
cultured RPE cells had a number of inherent limitations that
prevented extrapolation and generalization of findings to human
subjects. First, the mock, non-target siRNA procedure by itself
caused an increase in the pH of the lysosomes for an extended
period of time and therefore the resulting effect on the rates of
proteolytic degradation within the RPE could be interpreted only
in a hypothetical sense. Secondly, the CHM siRNA resulted in
only a 70% reduction in the level of expression of REP-1.
Measurable levels of REP-1 were still present, unlike that of the
cells from CHM patients, which in general lack REP-1. Finally,
the effect of the proprietary siRNA mixture was not validated for
splicing variants that are known for the CHM gene transcript (two
major and several tissue-specific ones). Therefore, by studying
naturally occurring mutations in the present work we were able to
overcome these limitations and address the pathogenesis of CHM
directly. Using this approach we clearly demonstrated for the fist
time, that levels of acidification in phagolysosomes are increased in
peripheral cells of CHM patients leading to the significantly
reduced rates of proteolytic degradation. Therefore, data
obtained from the RPE REP-1 siRNA model and contrasted with
that obtained from the study of peripheral cells of the CHM
patients reveal valuable and novel information with respect to
understanding the mechanism and development of the CHM
disease in the human population.
Exocytosis and Secretion Affected in Peripheral Cell from
CHM Patients
A number of genes involved in the immune response, small
GTPase regulation, secretion, the regulation of transcription, cell
adhesion and the regulation of exocytosis were significantly up-and
down-regulated in both fibroblasts and monocytes from CHM
patients. Under-prenylation of certain Rabs could alter exocytic
pathways and secretion in a variety of cells [35]. Previous studies
have suggested that the reduction or absence of REP1 could have
a variable effect on the prenylation of Rabs and therefore could
affect different aspects of the trafficking in the RPE and other cell
types [7,48,12]
We hypothesized that underprenylation of certain Rabs would
probably influence the pH level in lysosomes, and exocytosis/
secretion of cells. Indeed knock down of the CHM gene resulted in
an increase in the secretion of monocyte chemotactic protein-1
(MCP-1) and interleukin-8 (IL-8) by human fetal RPE cells [47].
These cells, while maintaining a polarity in culture, secreted more
MCP-1 and IL-8 to both apical and basal compartments in
culture. In contrast, fibroblasts from CHM patients, when
compared to normal controls, secreted significantly lower levels
of MCP-1, PEDF, TNF-alpha, FGF and IL-8. Differences
observed between the secretion patterns of the human fetal RPE
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could be explained by: (1) the differences in physiology of adult
and fetal tissues, (2) the difference in prenylation levels of specific
Rab proteins in RPE and other cell types leading to differences in
the regulation of secretion in different tissues. These effects of
relative absence of REP-1 and absence of REP-1 on secretion have
not been previously reported. Differences in the regulation of
secretion between the different cell types with reduced/absent
levels of REP-1 could explain the tissue specific degeneration that
occurs in choroideremia. For example, Rab27a plays a crucial role
in the exocytosis of lytic granules in cytotoxic T lymphocytes and
Rab27b is a key regulator of dense granule secretion in platelets
and other secretary cells [18,49,50,51,52]. Rab27 is also present at
high levels in the RPE and choriocapillaris and its under-
prenylation could contribute to the degenerative process. Inter-
estingly, whereas Rab27 is also expressed in a variety of secretary
and neuronal cells involved in synaptic transmission
[19,53,54,55,56]; neuronal degeneration, outside the retina, has
not been reported in CHM patients. Increased exocytic activity of
damaged RPE cells has been proposed to play a role in the
development of AMD and the retinal degeneration due to the
chloroquine toxicity. Possibly the disordered cell function observed
in fibroblasts and monocytes from CHM patients represents a
subclinical CHM phenotype that was not previously recognized
and offers the opportunity for further research.
Different Mutations in CHM Gene Could Affect mRNA
and Protein Stability
Mutated forms of REP-1 (Table 1), except L550P, were all
visibly absent in primary fibroblasts and monocytes derived from
CHM patients. Of interest, 4 mutations in the CHM gene (I460X,
Y504 X, L550P and I553X) occur in domain 2 (residues 93–270
and 447–553), almost the same area of the b-sheet formed by
residues 546–556, 450–460, 500–515 shown in cyan (Fig. 3A, B).
In addition, 7 mutations (P179X, K234X, I244X, I460X, Y504X,
L550P and I553X, Table 1) localized to the same domain.
While it has been suggested that all the mutations in CHM
patients lead to the loss of the REP-1, the mechanism of the loss
could range from nonsense-mediated decay of the coding mRNA
to the degradation of the truncated/misfolded REP-1 in the
endoplasmic reticulum. The latter mechanism could cause
significant stress and toxicity to the cell and eventually lead to
degeneration and cell death [57,58,59] In support of that, we
observed that a missense mutation (L550P), which does not change
the length of the protein significantly affects the level of REP-1 in
cells in fibroblasts of the patient [22]. We hypothesized that the
position of the mutation could significantly influence the stability
of REP-1 and the severity of the CHM phenotype. Since the
CHM RPE cells are not available for study, fibroblasts and
monocytes from patients are the only viable models of CHM that
allow genotype/phenotype correlations to be drawn; correlating
individual mutations with cellular defects and the clinical severity
of the disease. [60,61].
Surprisingly, we did not see a compensatory increase in the
protein and RNA levels of REP-2 in fibroblasts or monocytes from
CHM patients. REP-2 expression was uniformly found to be very
low. In addition, we observed a significant difference (more than
10 fold) in the levels of REP-1 mRNA in peripheral tissues of
patients carrying different CHM mutations. Some patients’ cells
demonstrated REP-1 mRNA levels similar to control; however, in
others the mRNA levels were quite low. Generally, low levels of
CHM mRNA could be explained by nonsense-mediated decay of
the transcript [31]. In our study, differences in mRNA levels
between CHM patients could be determined by the position of
mutations in REP-1 that may or may not target the mRNA for
nonsense-mediated decay. This observation could lead to
treatment strategies for patients, including chaperone molecules
to prevent RNA degradation or small molecules that force the read
through of premature stop codons in the CHM gene.
To date, no clinical studies have reported the effect of different
mutations in the CHM gene on tissues other than the eye. Our
observations indicate that despite the variety of mutations found in
CHM patients, in each case the effect of the mutation was the
same in disordering trafficking and exocytosis in fibroblasts and
monocytes. As well, the retinal phenotype of these patients was
typical of the spectrum expected at the various ages of the patients.
The peripheral tissues of CHM patients will be useful models that
reflect the defects in trafficking that underlie this retinal phenotype
and provide additional data to explain the mechanism REP-1
compensation.
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